Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform - PubMed (original) (raw)
Cavazza A, Molina-Estévez FJ, Reyes ÁP, Ronco V, Naseem A, Malenšek Š, Pečan P, Santini A, Heredia P, Aguilar-González A, Boulaiz H, Ni Q, Cortijo-Gutierrez M, Pavlovic K, Herrera I, de la Cerda B, Garcia-Tenorio EM, Richard E, Granados-Principal S, López-Márquez A, Köber M, Stojanovic M, Vidaković M, Santos-Garcia I, Blázquez L, Haughton E, Yan D, Sánchez-Martín RM, Mazini L, Aseguinolaza GG, Miccio A, Rio P, Desviat LR, Gonçalves MAFV, Peng L, Jiménez-Mallebrera C, Molina FM, Gupta D, Lainšček D, Luo Y, Benabdellah K. Cavazza A, et al. Mol Ther Nucleic Acids. 2025 Jan 17;36(1):102457. doi: 10.1016/j.omtn.2025.102457. eCollection 2025 Mar 11. Mol Ther Nucleic Acids. 2025. PMID: 39991472 Free PMC article. Review.